Wednesday, Feb 18, 2026
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"granules-india-limited"
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults
Latest News
Is it a crime to win majority of wards, Suman asks Vivek before arrest
7 mins ago
Deer killed in road accident in Kothagudem
19 mins ago
Speaker concludes hearing on disqualification petition against Danam Nagender
43 mins ago
Consumers’ body wants BIS Standards Clubs set up in schools, colleges in Telangana
45 mins ago
Telangana’s finances struggle over weak revenues and mounting debts
48 mins ago
IIT Hyderabad to host MSME Tech Connect 2026
50 mins ago
Khammam, Warangal police excel in Telangana Police Sports and Games Meet
1 hour ago
GHMC launches MyCURE app for faster civic grievance redressal
1 hour ago
.